Nevertheless, AGT siRNA offered renoprotection in this model (a reduction in glomerulosclerosis and diminished proteinuria), and this involved the suppression of renal Ang II independently of any blood pressure–lowering effect. The gene discussed is AGT; the disease is glomerulosclerosis.